Sugentech Inc - Asset Resilience Ratio
Sugentech Inc (253840) has an Asset Resilience Ratio of 21.72% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Sugentech Inc to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Sugentech Inc's Asset Resilience Ratio has changed over time. See how leveraged is Sugentech Inc's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Sugentech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Sugentech Inc worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩20.36 Billion | 21.72% |
| Total Liquid Assets | ₩20.36 Billion | 21.72% |
Asset Resilience Insights
- Good Liquidity Position: Sugentech Inc maintains a healthy 21.72% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Sugentech Inc Industry Peers by Asset Resilience Ratio
Compare Sugentech Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for Sugentech Inc (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Sugentech Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 25.25% | ₩24.80 Billion ≈ $16.81 Million |
₩98.21 Billion ≈ $66.56 Million |
-24.49pp |
| 2024-12-31 | 49.75% | ₩53.55 Billion ≈ $36.29 Million |
₩107.64 Billion ≈ $72.95 Million |
-0.32pp |
| 2023-12-31 | 50.07% | ₩66.68 Billion ≈ $45.19 Million |
₩133.19 Billion ≈ $90.26 Million |
-13.34pp |
| 2022-12-31 | 63.40% | ₩109.87 Billion ≈ $74.46 Million |
₩173.30 Billion ≈ $117.44 Million |
-6.24pp |
| 2021-12-31 | 69.64% | ₩108.34 Billion ≈ $73.42 Million |
₩155.56 Billion ≈ $105.42 Million |
+20.59pp |
| 2020-12-31 | 49.06% | ₩35.54 Billion ≈ $24.09 Million |
₩72.46 Billion ≈ $49.10 Million |
-15.92pp |
| 2019-12-31 | 64.97% | ₩29.51 Billion ≈ $20.00 Million |
₩45.42 Billion ≈ $30.78 Million |
+29.53pp |
| 2018-12-31 | 35.44% | ₩8.64 Billion ≈ $5.85 Million |
₩24.37 Billion ≈ $16.52 Million |
+17.02pp |
| 2017-12-31 | 18.42% | ₩3.37 Billion ≈ $2.28 Million |
₩18.28 Billion ≈ $12.39 Million |
-- |
About Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more